Ocular Oncology and Pathology
Log in to MyKarger to check if you already have access to this content.
Buy
FullText & PDF
Unlimited re-access via MyKarger
Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Select
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Learn more
Rent/Cloud
Rent for 48h to view
Buy Cloud Access for unlimited viewing via different devices
Synchronizing in the ReadCube Cloud
Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Select
Subscribe
Access to all articles of the subscribed year(s) guaranteed for 5 years
Unlimited re-access via Subscriber Login or MyKarger
Unrestricted printing, no saving restrictions for personal use
read more
Subcription rates
Select
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
Abstract
Introduction: To analyze the results of intraocular surgery in treated retinoblastoma eyes and to assess the long-term results with a priority on local recurrences, secondary enucleation and metastases.
Methods: Retrospective noncomparative case series.
Results: From March 1964 to January 2020, 43 eyes of 40 retinoblastoma patients underwent intraocular surgery. Time interval between last therapy and surgery was 9.5 years on average. Thirty eyes were treated for radiogenic cataract formation with a gain in visual acuity in 63.3%. One child developed an upper eyelid metastasis, 3 showed second primary malignancies (SPM), one a late recurrence and 2 eyes were enucleated. Retinal surgery was performed in 16 eyes, 6 eyes were done as a combined procedure. Indications were radiogenic complications in 10 eyes and a rhegmatogenous retinal detachment in 6 eyes. 43.75% had a postoperative gain in visual acuity. Two patients developed late recurrences, one a SPM and 4 eyes could not be preserved.
Conclusion: Surgical therapy in treated retinoblastoma is necessary in isolated cases. In our series cataract surgery was a safe procedure with a good option of a significant increase in visual acuity. Vitreoretinal treated eyes showed a limited gain in visual acuity, a higher risk of late recurrences and a lower globe retention rate. Therefore preoperative high-quality imaging and individual risk-benefit analysis is mandatory.
S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Comments (0)